Bracco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRACCO, and when can generic versions of BRACCO drugs launch?
BRACCO has forty approved drugs.
There are three US patents protecting BRACCO drugs.
There are thirty-four patent family members on BRACCO drugs in twelve countries and seventy-three supplementary protection certificates in eight countries.
Drugs and US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ISOVUE-200 | iopamidol | INJECTABLE;INJECTION | 018735-006 | Jul 7, 1987 | AP2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | VARIBAR NECTAR | barium sulfate | SUSPENSION;ORAL | 208143-004 | Jul 7, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | CHROMITOPE SODIUM | sodium chromate cr-51 | INJECTABLE;INJECTION | 013993-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | READI-CAT 2 SMOOTHIE | barium sulfate | SUSPENSION;ORAL | 208143-002 | Jan 15, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | RENOVUE-65 | iodamide meglumine | INJECTABLE;INJECTION | 017902-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | HIPPUTOPE | iodohippurate sodium i-131 | INJECTABLE;INJECTION | 015419-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | ISOVUE-300 | iopamidol | INJECTABLE;INJECTION | 018735-002 | Dec 31, 1985 | 4,001,323 | ⤷ Try a Trial |
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | 6,803,046 | ⤷ Try a Trial |
Bracco | MULTIHANCE | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021357-003 | Nov 23, 2004 | 4,916,246 | ⤷ Try a Trial |
Bracco | CHOLOVUE | iodoxamate meglumine | INJECTABLE;INJECTION | 018076-001 | Approved Prior to Jan 1, 1982 | 3,654,272 | ⤷ Try a Trial |
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | 5,686,060 | ⤷ Try a Trial |
Bracco | CHOLETEC | technetium tc-99m mebrofenin kit | INJECTABLE;INJECTION | 018963-001 | Jan 21, 1987 | 4,418,208 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bracco Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2020276679 | ⤷ Try a Trial |
South Africa | 202108096 | ⤷ Try a Trial |
Singapore | 11202111756U | ⤷ Try a Trial |
European Patent Office | 3817777 | ⤷ Try a Trial |
South Korea | 20220008827 | ⤷ Try a Trial |
Canada | 3137089 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bracco Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1178838 | 300736 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
1556389 | 92943 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CEFTOLOZANE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, EN PARTICULIER UN SEL D'ACIDE SULFURIQUE (ZERBAXA); FIRST REGISTRATION: 20150922 |
1856135 | CA 2020 00018 | Denmark | ⤷ Try a Trial | PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113 |
1874117 | 2014/032 | Ireland | ⤷ Try a Trial | PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121 |
0480717 | 98C0022 | France | ⤷ Try a Trial | PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825 |
2380576 | 2020/043 | Ireland | ⤷ Try a Trial | PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; NAT REGISTRATION NO/DATE: PA2103/003/001 20170602; FIRST REGISTRATION NO/DATE: SE/H/1547/001/DC 20160729 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.